BAAR, Switzerland–(BUSINESS WIRE)–CorFlow Therapeutics AG (www.corflow-therapeutics.ch) today announced that the company has completed the 2nd close of its Seed+ financing round. To date, and since the CorFlow foundation in 2016, the company has raised a total of USD 9.7M (CHF 9.4M) in seed funding. The seed rounds have been funded by experienced private […]
Other News
With Latest FDA 510(k), physIQ Achieves Another Clearance as a Pioneer in AI Analytics
CHICAGO–(BUSINESS WIRE)–PhysIQ, a leader in applying AI analytics to biosensor data, today announced it has received FDA 510(k) clearance for its Atrial Fibrillation (AFib) detection analytics engine. The clearance extends physIQ’s portfolio of FDA 510(k) cleared analytics designed to generate clinical insight from wearable biosensors and further establishes physIQ as a […]
CellAegis Announces Completion of Patient Enrollment in First North American Study for Innovative Heart Attack Therapy Using autoRIC®
TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) — CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for acute and chronic cardiovascular conditions, today announced completion of patient enrollment in a large scale, investigator sponsored study (“FIRST”) to evaluate the clinical […]
BioSig Technologies, Inc. Announces 1-for-2.5 Reverse Stock Split for Pending Uplist to Nasdaq
Santa Monica, CA, Sept. 10, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM, OTCQB: BSGMD) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company […]
BioSig Technologies Issues Shareholder Letter
Santa Monica, CA, Sept. 11, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD) a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has issued their September 2018 letter […]
Fujifilm Continues Partnership with American College of Radiology, Supports Education Center with Synapse® Enterprise Imaging
STAMFORD, Conn., Sept. 11, 2018 /PRNewswire/ — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Informatics solutions, is continuing its partnership with the American College of Radiology (ACR), a professional medical society at the forefront of innovation and education in radiology. Fujifilm provides Enterprise Imaging solutions, Synapse PACS and 3D, to support […]
Baylis Medical Expands Transseptal Portfolio with Launch of Steerable Guiding Sheath
TORONTO, Sept. 10, 2018 /PRNewswire/ – Baylis Medical Company, a leader in the development, manufacturing and commercialization of cardiology devices, announced the official commercial launch of its SureFlex® Steerable Guiding Sheath. The SureFlex sheath is part of Baylis’ rapidly growing portfolio of high-performance products for transseptal access. The sheath features an advanced sheath-to-dilator […]
Neovasc Announces Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
VANCOUVER, Sept. 11, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ : NVCN )(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today (1) that it has received the decision of the […]
Seqster joins American Heart Association Center for Health Technology and Innovation
SAN DIEGO, Sept. 11, 2018 /PRNewswire/ — Seqster the leading consumer-centric health data management platform empowering employees, members, or patients to collect, own and share all of their health data, today joined the American Heart Association’s Center for Health Technology and Innovation (CHTI) Health Tech Collaborative. The collaboration will combine AHA’s data-driven approaches with Seqster’s […]
FDA Designates AliveCor’s Bloodless Hyperkalemia Test a “Breakthrough Device”
MOUNTAIN VIEW, Calif., Sept. 10, 201 /PRNewswire/ — AliveCor, recently recognized as the Most Innovative Company in Artificial Intelligence, today announced that the U.S. Food and Drug Administration has given the company’s KardiaK Software Platform the rarely granted designation of “Breakthrough Device.” This designation means that the FDA will consider the technology […]